Every reference with a DOI in the deposited reference list resolved to a known
work in Crossref or DataCite at the dated check, and none carried a retraction,
withdrawal, or removal notice.
The 44 checked references that resolve
resolves10.1523/JNEUROSCI.1734-20.2020Complement Drives Synaptic Degeneration and Progressive Cognitive Decline in the Chronic Phase after Traumatic Brain Injury
resolves10.1186/s12974-015-0464-8Modulation of post-stroke degenerative and regenerative processes and subacute protection by site-targeted inhibition of the alternative pathway of complement
resolves10.1126/scitranslmed.aao6459Targeted complement inhibition salvages stressed neurons and inhibits neuroinflammation after stroke in mice
resolves10.1007/s12975-017-0551-5Preclinical and Clinical Evidence on Ipsilateral Corticospinal Projections: Implication for Motor Recovery
resolves10.1016/j.bbr.2016.08.029Factors affecting post-stroke motor recovery: Implications on neurotherapy after brain injury
resolves10.1161/CIRCULATIONAHA.114.010482Targeting Pathogenic Postischemic Self-Recognition by Natural IgM to Protect Against Posttransplantation Cardiac Reperfusion Injury
resolves10.1016/S1474-4422(16)00114-9Neuroprotection in acute stroke: targeting excitotoxicity, oxidative and nitrosative stress, and inflammation
resolves10.1186/1742-2094-9-179Extensive innate immune gene activation accompanies brain aging, increasing vulnerability to cognitive decline and neurodegeneration: a microarray study
resolves10.1189/jlb.0208108Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system
resolves10.4049/jimmunol.1102132Pathogenic Natural Antibodies Propagate Cerebral Injury Following Ischemic Stroke in Mice
resolves10.1016/S0140-6736(16)00163-XEndovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
resolves10.4049/jimmunol.181.11.8068A Novel Targeted Inhibitor of the Alternative Pathway of Complement and Its Therapeutic Application in Ischemia/Reperfusion Injury
resolves10.3389/fimmu.2020.02021Anti-inflammatory and Neuroprotective Agents in Clinical Trials for CNS Disease and Injury: Where Do We Go From Here?
resolves10.3390/ijerph7124111Pathophysiological Impact of Cigarette Smoke Exposure on the Cerebrovascular System with a Focus on the Blood-brain Barrier: Expanding the Awareness of Smoking Toxicity in an Underappreciated Area
resolves10.1186/s12974-015-0314-8Aging increases microglial proliferation, delays cell migration, and decreases cortical neurogenesis after focal cerebral ischemia
resolves10.1186/1471-2202-15-51Oxidative and pro-inflammatory impact of regular and denicotinized cigarettes on blood brain barrier endothelial cells: is smoking reduced or nicotine-free products really safe?
resolves10.1056/NEJMoa1706442Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
resolves10.1161/STROKEAHA.114.005252Combined Effects of Socioeconomic Position, Smoking, and Hypertension on Risk of Ischemic and Hemorrhagic Stroke
resolves10.4049/jimmunol.1502021Age-Associated Resident Memory CD8 T Cells in the Central Nervous System Are Primed To Potentiate Inflammation after Ischemic Brain Injury
resolves10.1080/00207454.2018.1538990Predictors of poor cerebral collaterals and cerebrovascular reserve in patients with chronic total carotid occlusion
resolves10.1177/0271678X17718966Aerobic exercise prevents rarefaction of pial collaterals and increased stroke severity that occur with aging
resolves10.2174/138161206777947470Inflamm-Aging, Cytokines and Aging: State of the Art, New Hypotheses on the Role of Mitochondria and New Perspectives from Systems Biology
resolves10.1371/journal.pone.0067894Alternative Complement Pathway Deficiency Ameliorates Chronic Smoke-Induced Functional and Morphological Ocular Injury
resolves10.1056/NEJMoa2001123Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke
resolves10.5414/CP203117Predictors of functional outcome and hemorrhagic complications in acute ischemic stroke patients treated with intravenous thrombolysis – A retrospective analysis
The 11 references without a DOI — listed, not checked
no DOI — not checkedref16
no DOI — not checkedref18
no DOI — not checkedref22
no DOI — not checkedref28
no DOI — not checkedref29
no DOI — not checkedref31
no DOI — not checkedref32
no DOI — not checkedHow can we improve stroke thrombolysis rates? A review of health system factors and approaches associated with thrombolysis administration rates in acute stroke care
no DOI — not checkedref49
no DOI — not checkedref50
no DOI — not checkedref52
checked 2026-07-23 — re-checked daily as this page is visited;
titles and statuses come from Crossref and DataCite and are not part of the signed record
Both snippets point at the live badge image and link back to this page. The
badge re-renders from the daily check, so an embed never goes stale by more than a day of visits.